Status:
COMPLETED
Is Primiparity a Risk Factor for Neonatal Hyperbilirubinemia?
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Hyperbilirubinemia, Neonatal
Eligibility:
All Genders
Up to 14 years
Brief Summary
Neonatal hyperbilirubinemia elongates hospital stay and may require treatment. The investigators noticed that bilirubin levels were higher among infants of primipara mothers than among multipara mothe...
Detailed Description
Neonatal hyperbilirubinemia elongates hospital stay and may require treatment. The investigators noticed that bilirubin levels were higher among infants of primipara mothers than among multipara mothe...
Eligibility Criteria
Inclusion
- All infants that were born during one year in a single medical center and were transferred to well baby nursery, and were discharged from the well baby nursery.
Exclusion
- Infants who were transferred to neonatal intensive care unit due to any reason.
- Infants whose mother could not take care of them (due to admission to intensive care unit, or due to adoption)
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 20 2018
Estimated Enrollment :
4369 Patients enrolled
Trial Details
Trial ID
NCT03329040
Start Date
January 1 2018
End Date
September 20 2018
Last Update
September 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe medical center
Hadera, Hadera, Israel, 38100